South Korea · Biotechnology startup
South Korea · AbTis
AbTis is a biotechnology company that provides antibody-drug conjugation technology and solubilization.
Funding reportedLast round: Series B
What company datasets say AbTis raised
Funding, as reported
Reported in all15Bin the source's currency
Rounds1
Last roundSeries B
Last round dateFeb 2021
Investors listed7
Biotechnology in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put AbTis in front of investors. Or tell us what we have wrong.